We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GTHX market cap is 140.42M. The company's latest EPS is USD -0.9189 and P/E is -2.91.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.95M | 42.39M | 12.3M | 14.87M | 14.48M |
| Operating Income | -25.75M | 12.61M | -16.37M | -8.93M | -9.05M |
| Net Income | -27.6M | 8.71M | -18.2M | -10.88M | -10.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 45.29M | 31.48M | 51.3M | 82.51M |
| Operating Income | -129.04M | -96.48M | -142.46M | -136.18M | -39.53M |
| Net Income | -122.45M | -99.25M | -148.35M | -147.56M | -47.97M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 161.96M | 147.89M | 133.1M | 121.54M | 102.03M |
| Total Liabilities | 116.97M | 90.34M | 90.08M | 86.15M | 74.29M |
| Total Equity | 44.99M | 57.55M | 43.02M | 35.39M | 27.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 284.83M | 228.55M | 254.09M | 187.97M | 121.54M |
| Total Liabilities | 29.3M | 51.2M | 110.55M | 119.22M | 86.15M |
| Total Equity | 255.53M | 177.35M | 143.54M | 68.75M | 35.39M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.05M | -14.97M | -25.55M | -38.34M | -8.9M |
| Investing | 2.91M | 3.26M | 10.46M | 2.81M | 5.29M |
| Financing | -214k | -26.97M | -26.95M | -26.91M | -8.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -99.57M | -83.74M | -132.11M | -128.62M | -38.34M |
| Investing | -2.72M | 152k | N/A | -50.53M | 2.81M |
| Financing | 2.71M | 21.69M | 145.86M | 52.5M | -26.91M |
| Market Cap | 140.42M |
| Price to Earnings Ratio | -2.91 |
| Price to Sales Ratio | 1.69 |
| Price to Cash Ratio | 4.33 |
| Price to Book Ratio | 3.94 |
| Dividend Yield | - |
| Shares Outstanding | 52.2M |
| Average Volume (1 week) | 513.18k |
| Average Volume (1 Month) | 817.36k |
| 52 Week Change | -4.27% |
| 52 Week High | 6.14 |
| 52 Week Low | 1.08 |
| Spread (Intraday) | 0.05 (1.83%) |
| Company Name | G1 Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.g1therapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
